HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Columbia Labs Advantage-S Additional HIV Prevention Trials Unlikely

This article was originally published in The Tan Sheet

Executive Summary

"It will be very difficult to conduct another study" on Advantage-S (nonoxynol-9) and HIV prevention after a Joint U.N. Program on HIV/AIDS trial produced negative results, Columbia Labs Chairman and CEO William Bologna asserted during a June 12 conference call.

You may also be interested in...

Microbicide Trial “Condom Only”-Arm Designs To Be Reviewed By FDA Cmte.

FDA is seeking guidance from the Antiviral Drugs Advisory Committee as to whether clinical trials on topical microbicides should include a "no treatment" (condom only) arm

N-9 Lubricated Condom Buys, Spermicide Use Discouraged In CDC Guidelines

The Centers for Disease Control & Prevention is advising against future purchases of condoms lubricated with nonoxynol-9 (N-9) spermicide

Nonoxynol-9 Microbicidal Ineffectiveness Cited In JAMA Study, Editorial

A recent study on nonoxynol-9 gel confirms its inadequacy as a microbicide and lends further proof of its suspected irritant effects, according to an editorial in the March 6 Journal of the American Medical Association

Related Content





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts